Statistics for Pangaea Oncology SA (id:4789 PANG)
Valuation metrics
Market cap
58.26M
Enterprise value
53.43M
Trailing P/E (ttm)
Forward P/E
-57.00
PEG ratio
Price/Sales (ttm)
5.85
Price/Book (mrq)
2.89
Enterprise Value/Revenue
5.37
Enterprise Value/EBITDA
-19.83
Overview
Shares outstanding
34.07M
Float
10.48M
Shares short
% Held by insiders
3.00%
% Held by institutions
0.00%
Average volume (10 days)
333.00
Average volume (90 days)
Price summary
52-Week low
1.47
52-Week high
1.80
52-Week change
14.04%
Beta
5.00
50-Day moving average
1.77
200-Day moving average
1.56
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
December 31, 2023
Profitability
Profit margin
-46.78%
Operating margin
-34.59%
Operational effectiveness
Return on assets
-7.52%
Return on equity
-22.89%
Income statement
Revenue (ttm)
3.00
Revenue per share (ttm)
3.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
7.75M
EBITDA
-2,694,434.00
Net income to common (ttm)
-4,656,398.00
Diluted EPS (ttm)
3.00
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
2.79M
Total cash per share (mrq)
5.00
Total debt (mrq)
3.38M
Total Debt/Equity (mrq)
17.99
Current ratio (mrq)
134.30%
Book value per share (mrq)
3.00
Cash flow
Cash flow statement
-2,397,518.00
Levered free cash flow (LFCF)
197.52K